JPRN-UMIN000008918招募中未知
ow dose of lenalidomide and dexamethasone therapy for eldery multiple myeloma - Mini-Rd for eldery multiple myeloma
ishiwaki municipal hospital0 个研究点目标入组 26 人开始时间: 2012年9月14日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 26
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 70years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •*Patients who have allergy for the drugs used in this study *Patients who have active infectious disease *Patients who are decided as inappropriate by corresponding doctor.
研究者
相似试验
进行中（未招募）
1 期
The combination of Lenalidomide and Dexamethasone with or without intensification by high-dose Melphalan in the treatment of multiple myelomaprimary treatment of multiple myeloma patients of age 60 till 75 yearsMedDRA version: 21.0Level: LLTClassification code 10028228Term: Multiple myelomaSystem Organ Class: 100000004864EUCTR2008-004083-39-DEGMIHO Gesellschaft für Medizinische Innovation – Hämatologie und Onkologie mbH348
已完成
不适用
ow-dose lenalidomide plus dexamethasone after initial therapy with melphalan and prednisone in myeloma patients ineligible for stem cell transplantatioMultiple myelomaJPRN-UMIN000007889Department of Hematology and Rheumatology, Tohoku University Hospital30
招募中
不适用
Safety and efficacy of lenalidomide, dexamethasone, and clarithromycin therapy in Japanese patients with multiple myeloma, a phase I/II studyMultiple MyelomaJPRN-UMIN000007918ara Hospital Kinki University School Of Medicine32
进行中（未招募）
3 期
A clinical trial to study the effects of two drugs, Lenalidomide and Thalidomide given with low dose of Dexamethasone in patients with Multiple MyelomaCTRI/2015/06/005944Dr Reddys Laboratories Ltd
已完成
2 期
Efficacy and safety of lenalidomide and dexamethasone as consolidation therapy and lenalidomide as maintenance therapy after autologous stem cell transplantation for newly diagnosed multiple myelomaMultiple myelomaJPRN-UMIN000019918Gifu University Hospital20